FCMT
BBH icon

Founders Capital Management (Texas)’s VanEck Biotech ETF BBH Stock Holding History

Founders Capital Management (Texas)’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8K Hold
100
– – 0.01% 257
2025
Q4 		$18.9K Hold
100
– – 0.01% 248
2025
Q3 		$16.6K Hold
100
– – 0.01% 256
2025
Q2 		$15.3K Hold
100
– – 0.01% 252
2025
Q1 		$15.7K Hold
100
– – 0.01% 245
2024
Q4 		$15.7K Hold
100
– – 0.01% 248
2024
Q3 		$17.7K Hold
100
– – 0.01% 247
2024
Q2 		$16.8K Hold
100
– – 0.01% 249
2024
Q1 		$16.6K Hold
100
– – 0.01% 248
2023
Q4 		$16.5K Hold
100
– – 0.01% 249
2023
Q3 		$15.6K Hold
100
– – 0.01% 251
2023
Q2 		$15.6K Hold
100
– – 0.01% 266
2023
Q1 		$16K Hold
100
– – 0.01% 264
2022
Q4 		$16K Hold
100
– – 0.01% 251
2022
Q3 		$14K Hold
100
– – 0.01% 259
2022
Q2 		$15K Buy
+100
New +$14.9K 0.01% 262

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Founders Capital Management (Texas)'s BBH Position: Q1 2026 in Review

Founders Capital Management (Texas) held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 100 shares worth $18.8K. The position accounts for 0.01% of the portfolio, ranked #257.

Founders Capital Management (Texas) first reported a position in BBH in Q2 2022 and has held it in 16 quarters since. The position peaked at $18.9K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Founders Capital Management (Texas) held 100 shares of VanEck Biotech ETF worth $18.8K as of Q1 2026.
  • Founders Capital Management (Texas) left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up 0.01% of Founders Capital Management (Texas)'s portfolio in Q1 2026, its #257 holding.
  • Founders Capital Management (Texas) first reported a position in VanEck Biotech ETF in Q2 2022 and has held it in 16 quarters since.
  • Founders Capital Management (Texas)'s VanEck Biotech ETF position peaked at $18.9K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2026, filed 21 Apr 2026.